|
Geographic Management of Cancer Health Disparities Program (GMaP) Region 1-South
August 12, 2022 Newsletter
|
|
|
GMaP is an integrated network of three regions within the United States. The GMaP R1S hub is based at the UNC Lineberger Comprehensive Cancer Center and in partnership with the Hollings Cancer Center and Vanderbilt-Ingram Cancer Center, serves North Carolina, South Carolina and Tennessee.
|
|
|
You are receiving this newsletter as a Cancer Researcher in GMaP Region 1-South.
|
|
|
|
|
SAVE THE DATE
AACR Health Disparities Conference GMaP Region 1-South Reception
Saturday, September, 18th 2022
GMaP Region 1-South will be hosting a reception at the Annual AACR Health Disparities Conference on the evening of September 18th. We will be providing food and drinks and the opportunity to discuss GMaP Sunset Plans.
We will send more details soon and would love to see you there!
|
|
2022 Underrepresented Postdoctoral Fellow Recruitment Day
UNC Lineberger Comprehensive Cancer Center is soliciting applications for the Underrepresented Postdoctoral Fellow Recruitment Day on October 12, 2022.
This event is intended for PhD students and postdoctorates interested in postdoctoral research training/fellowship opportunities at UNC Lineberger, including through one of our NIH-funded T32 grant-supported training programs. Travel, food and lodging expenses will be supported.
Candidates selected for the 2022 Underrepresented Postdoctoral Recruitment Day will also have the option to attend the UNC Lineberger Comprehensive Cancer Center 47th Annual Postdoctoral/Faculty Research Day the following day, Oct 13, 2022, during which candidates will have an opportunity to present their research if desired.
Eligible candidates must be currently enrolled in or have completed a PhD or equivalent doctoral degree program, and must identify as belonging to a group that is underrepresented group in the U.S. biomedical, clinical, behavioral and social sciences, in accordance with NIH guidelines. Eligibility is therefore extended to: individuals from underrepresented racial and ethnic groups in biomedical research (Blacks or African Americans, Hispanics or Latinos, American Indians or Alaska Natives, and Native Hawaiians and other Pacific Islanders), individuals with disabilities (those with a physical or mental impairment substantially limiting major life activities, as described in the Americans with Disabilities Act of 1990); and Individuals from disadvantaged or low socioeconomic status backgrounds (see NIH guidelines for criteria). Women from the above groups are strongly encouraged to apply.
The deadline to apply has been extended to August 15, 2022. Candidates will be chosen and notified of selection shortly thereafter. If you are eligible and interested to attend, please submit an application.
Submit Event Application
|
|
News - Events - Conference
Reminder: Stimulus Award Applications Still Rolling
GMaP Region 1-South
Cancer Health Disparities Professional Development and Research Stimulus Awards – Round 3
Researchers from HBCUs and Tribal Colleges/Universities are Strongly Encouraged to Apply
Deadline: Rolling
Funding Amount: Up to $10,000 per award
Access Application
The goal of the GMaP Region 1-South Cancer Health Disparities Professional Development and Research Stimulus Awards is to facilitate the development of a diverse cadre of cancer researchers from high school to early stage faculty. The Region 1-South Cancer Health Disparities Professional Development and Research Stimulus Awards are merit awards made to individuals, not institutions, to support a range of cancer research activities, including the purchase of research-related resources (e.g., laboratory research supplies and equipment, transcription fees, data purchase or reuse fees, software, publication fees), research training (e.g., statistical or research methods courses), travel (e.g., presentation at a professional meeting or conference), pilot research study expenses, and other professional development or research-related expenses (e.g., poster printing).
Applications are strongly encouraged from cancer investigators who are underrepresented in the biomedical sciences according to NIH guidelines for underrepresented populations or research trainees conducting cancer disparities research. We welcome applications from any discipline and institution across the Region 1-South region (NC, SC, and TN) with priority given to Historically Black and Tribal Colleges and Universities.
All expenses must be invoiced by November 30, 2022. Available funding per awardee will vary depending on the nature of the request and justification for the funding with two tiers of funding described below.
Tier 1: Up to $5,000 (below is a non-exhaustive set of example expenses appropriate for Tier 1 funding):
- Registration and travel costs for professional meetings or conferences (priority given to applicants presenting research/abstracts at such meetings)
- Registration for training courses and workshops
- Publication costs
- Abstract submission and poster printing costs for professional meetings or conferences
- Biostatistical analyst or research consultant costs
Previous GMaP Region 1-South awardees have used funds to attend annual meetings hosted by the American Association of Cancer Research (AACR), American Society of Clinical Oncology (ASCO), and Advancing the Science of Cancer in Latinos, as well as professional development programs such as the SITC Cytokines in Immunotherapy Workshop and the Statistical Horizons Propensity Score Analysis seminar.
Tier 2: $5,001 - $10,000 (below is a non-exhaustive set of example expenses appropriate for Tier 2 funding):
- Research that generates initial or basic discoveries relevant to cancer regardless of whether the context of the discovery is the laboratory or the field
- Expert consultations with senior researchers
- Support for building and sustaining community advisory boards
- Providing summer mentored-research experience to underrepresented students ranging from high school to undergraduate
- Research consultancy fees to support HBCU and Tribal College/University faculty engaged in research and mentoring
- Non-computer equipment such as software
- Costs associated with the processing/assaying of biospecimens
- Purchase of secondary data or assembly of data/analytic datasets
- Incentives for research participants
- Transcription costs
This article is a useful reference for thinking about planning pilot research.
These merit awards are unique in that they are meant to support professional development of individual promising researchers in a variety of ways. As such, they are not typical research awards and will not be processed through institutional Offices of Sponsored Research. These awards may NOT be used for (1) institutional salary support for post-doctoral or faculty-level applicants, (2) office supplies, durable equipment or computers, (3) meals, or (4) institutional indirect costs. The funds are intended to support individual researchers’ professional development directly and are evaluated based upon individual merits and do NOT permit institutional indirect costs.
This award is open to all developing cancer researchers who are members of GMaP Region 1-South (i.e., high school students, undergraduate students, graduate students, post-docs, early-stage faculty, and faculty mentors from HBCU or Tribal Colleges/Universities) who are underrepresented in the biomedical sciences or studying cancer health disparities. If you are not a member of Region 1-South, you can join by emailing us at gmapregion1s@gmail.com.
All Tier 2 applicants must include a faculty research mentor. The faculty research mentor does not have to be a member of GMaP Region 1-South.
The GMaP Region 1-South Cancer Health Disparities Professional Development and Research Stimulus Awards will be processed in multiple ways, depending on the scope and nature of individual award requests. All funds must be expended and invoiced by November 30, 2022. GMaP Region 1-South staff will work with funded projects throughout the funding period to monitor progress and provide assistance where necessary. A final report of outcomes will be required. Additionally, GMaP Region 1-South expects awardees to acknowledge the award in any related publications, presentations, or other academic products emerging from the work. A funding disclosure statement will be provided to awardees to use for this purpose.
Applications should be presented in a clear and logical fashion, make a convincing case for the significance of the work or how the funding will stimulate research or development as a research scholar, and describe the proposed use of funds in sufficient detail so that an adequate evaluation of the application can be made. The review committee will be comprised of a diverse community of reviewers who are Cancer Center faculty as well as HBCU or Tribal College/University faculty from the three GMaP Region 1-South regions.
The following review criteria will be considered (not exhaustive given the variety of applications to be considered):
- Significance of the work or potential for the funds to directly advance the applicant’s career development
- Potential to lead to future external funding, publications, or other research products
- Soundness of the proposed methods (if relevant) or appropriateness of career development activities
***Please note: Projects that will require a new, full human subjects IRB application for review will not be considered due to the funding time window. However, projects that will require an IRB modification or be expected to be exempted from full review will be considered.
- Feasibility of accomplishing all stated project goals and expensing funds by November 30, 2022
- Abstract: A summary of the application (200 word maximum).
- Career Impact: Briefly describe the likelihood for your project/funding request to influence your development as a researcher (500 word maximum).
- Research or Career Development Plan (Upload): Research Plans should include Goals, Background, Approach, and Timeline. Career Development Plans should include Goals, Personal Statement, Career Development Activities, and Timeline. Please use double line spacing, font Arial 11 pt., and 1-inch margins all around. (No more than 3 pages allowed, including tables and figures. References do not count towards the page limit and should be appended to the end of the plan, where relevant.)
- Budget Justification (Upload): Include sufficient detail for reviewers to assess the appropriateness for the funding relevant to your research and/or professional development goals.
- NIH Biosketch (Faculty applicants) or Curriculum Vitae/Resume (All non-faculty applicants) (Upload).
- Name(s) and contact information for research mentor(s) (optional for Tier 1, required for Tier 2)
- Name(s) and contact information for applicant’s departmental business manager/administrator (required)
If you have any additional questions about this application process or eligibility, please contact our Regional Coordinating Director Anissa Vines and Administrative Coordinator Erin Laurie by emailing gmapregion1s@gmail.com. You can also reach Dr. Vines directly at avines@email.unc.edu, and Ms. Laurie at erin_laurie@med.unc.edu.
|
|
|
Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control, U54 Clinical Trial Optional). The purpose of the Global Implementation Science for Equitable Cancer Control (GlobalISE Cancer Control) Funding Opportunity Announcement (FOA) is to build implementation science centers in low- and middle-income countries (LMICs). This initiative will support implementation science research capacity-building activities, including research projects that identify, develop, and test innovative theory-based strategies for overcoming barriers to the adoption, adaptation, integration, scale-up, and sustainability of evidence-based cancer control interventions in LMICs. Application due date: November 8, 2022.View the CGH list of funding for global cancer research and training.
|
|
New Post Doctoral Fellowship Opportunities!
|
|
We are excited to let you know that NHLBI has released two companion FOAs with the entitled of “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-015.html and “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-016.html along with the notice of availability of Frequently Asked Questions (FAQs) (https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-027.html).
|
|
Administrative Supplements to Support Cancer Disparity Collaborative Research Funding Opportunity Reissued
The National Cancer Institute is excited to announce the reissuance of a Funding Opportunity Announcement (FOA) to solicit applications for Administrative Supplements to Support Cancer Disparity Collaborative Research (Clinical Trial Optional) (the Collaborative), now published as PAR-22-114. We encourage you to share this funding opportunity with your grantees and networks.
Overview
The Collaborative FOA seeks to catalyze and broaden research and collaborations across the Cancer Health Disparities (CHD) spectrum. Key facts about the Collaborative:
- Supports new CHD research among investigators who do not normally conduct it and encourages the partnership of experienced cancer research investigators with CHD-focused researchers.
- Aims to accelerate and strengthen multi-disciplinary CHD research in wide-ranging areas. CHD research includes, but is not limited to basic, translational, behavioral, observational, interventional, environmental, and population research studies that address the adverse differences in cancer incidence, prevalence, mortality, survivorship, burden, and/or response to treatment in racial/ethnic minorities and/or underserved population groups.
- Proposed collaborations should focus on achieving research objectives that by necessity rely on diverse and complementary expertise, technical capabilities, and resource sets.
Importantly, the supplemental proposal is required to be within the scope of the parent award and should expand the original aims to include a CHD component and possible inclusion of international comparator cohorts. A trans-NCI effort, the reissuance of the Collaborative is supported by NCI’s Division of Cancer Biology, Division of Cancer Treatment and Diagnosis, Division of Cancer Prevention, Division of Cancer Control and Population Sciences, Center to Reduce Cancer Health Disparities (CRCHD), and Center for Global Health.
Applicants are encouraged to access the fact sheet and to apply early to allow adequate time to correct errors found during the submission process.
Key Dates
- Pre-Application Webinar: Program Staff will host a pre-application webinar on Friday, August 5, 2022 from 2:00-3:00 pm Eastern. Register now.
- Due Date: September 6, 2022
- Earliest Start Date: August 2023
Questions
Need more information or have questions? Contact NCI Center to Reduce Cancer Health Disparities Program Director Dr. Maria Jamela (Jay) Revilleza, mariajamela.revilleza@nih.gov.
|
|
The Howard Hughes Medical Institute (HHMI) recently committed 1.5 billion dollars to increase diversity, equity, and inclusion by creating the Freeman Hrabowski Scholars Program. This program is for early-career faculty, including basic researchers and physician-scientists, who have strong potential to become leaders in their fields and advance diversity, equity, and inclusion through their mentorship and understanding of trainees' experiences from races and ethnicities underrepresented in US science.
Dr. Freeman A. Hrabowski III is the outgoing president of the University of Maryland, Baltimore County (UMBC) and is responsible for the Meyerhoff Scholars Program for undergraduate students.
The new HHMI program is accepting applications until September 28, 2022. Details of the program and application instructions are at https://www.hhmi.org/programs/freeman-hrabowski-scholars#Overview. This opportunity may be excellent for some of our CURE/CRCHD ESIs.
|
|
|
|
The summer application period is officially open for research presentations and travel scholarships to the 2022 SACNAS National Diversity in STEM (NDiSTEM) Conference. Attending a conference is a critical component of student's academic and professional development as they navigate their path in STEM. Please take a moment and forward this email to your students to share these opportunities to broaden their networks, access mentorship, and so much more at #2022NDiSTEM!
|
|
Data and Technology Advancement (DATA) National Service Scholar Program: Data Scientists Advancing Biomedical Research
The National Institutes of Health (NIH) Office of Data Science Strategy (ODSS) Data and Technology Advancement (DATA) National Service Scholar Program is seeking experienced data and computer scientists and engineers to tackle challenging biomedical data problems with the potential for substantial public health impact.
Today, biomedical datasets are measured in petabytes and comprise data types ranging from DNA sequences to wearable sensor-generated outputs like heart rate. NIH envisions a biomedical enterprise in which data and information generated in the field, laboratory, and clinic are processed and analyzed in real-time and readily shared. In an increasingly data-rich world, these advances are essential to the NIH mission of enhancing health, lengthening life, and reducing illness and disability.
Achieving this vision requires deep experience in, and knowledge of, data and computer sciences and related fields. To bring talented professionals with this necessary expertise to advance high-impact NIH programs, the ODSS created the DATA National Service Scholar Program. DATA Scholars will substantially optimize and accelerate data science in biomedicine to improve human health and well-being. The program will also encourage transformative approaches that lead to increased efficiency, innovative research, tool development, and analytics.
https://datascience.nih.gov/data-scholars-2022
|
|
|
TENURE-ELIGIBLE PRINCIPAL INVESTIGATOR AND HEALTH DISPARITIES PROGRAM LEADER
The Center for Cancer Research (CCR) at the National Cancer Institute (NCI), National Institutes of Health (NIH) in Bethesda, Maryland is seeking a world-class tenure-eligible investigator focused on health disparities in cancer to both conduct an independent research program and to lead CCR’s institutional efforts to boldly expand our health disparities research portfolio.
This position is located in the Laboratory of Human Carcinogenesis (LHC) and the candidate will complement the current group of dynamic and collaborative principal investigators (https://ccr.cancer.gov/laboratory-of-human-carcinogenesis#lab-staff-tab-2). The candidate must be an internationally recognized leader in the field of health disparities with demonstrated research productivity in molecular and biological epidemiology with a goal to develop an outstanding independent molecular-based program in health disparities (ideally in lung cancer) at CCR. The successful candidate will be appointed at the level of tenured NIH Senior Investigator, equivalent to Associate/Full Professor in an academic department. The incumbent’s research program will be supported with stable financial resources of the NCI intramural program and full access to a wide range of institutional technology platforms and the NIH Clinical Center.
Applications must be submitted to: https://service.cancer.gov/ccr-careers. Initial review of applications will begin in early June 2022, but applications will be accepted until the position is filled. Applications will be treated as confidential. For more information, contact Lori Holliday, Faculty Recruitment Coordinator at hollidal@mail.nih.gov.
Selection for this position will be based solely on merit, with no discrimination for non-merit reasons such as race, color, religion, gender, sexual orientation, national origin, political affiliation, marital status, disability, age, or membership or non-membership in an employee organization. NIH provides reasonable accommodations to applicants with disabilities. If you require reasonable accommodation during any part of the application and hiring process, please notify us. The decision on granting reasonable accommodation will be made on a case-by-case basis. This position is subject to a background investigation.
|
|
NCI Support for Early-Stage Investigators
 NIH Early-Stage Investigators (ESIs) are defined as having completed their terminal research degree or end of post-graduate clinical training, whichever date is later, within the past 10 years and who have not previously competed successfully as Principal Investigator for a substantial NIH independent research award. Read more about NIH ESI status.
NCI is strongly committed to supporting ESIs and places special emphasis on supporting ESIs with R01 applications. This Fiscal Year 2022, NCI has an ESI R01 payline of the 16th percentile as compared to the established investigator R01 payline of the 11thpercentile. Read more about NCI FY2022 Funding Policy.
Got questions? We’ve got answers! Visit the frequently asked questions page for NIH ESIs. |
|
|
New Find Funding Wizard!
New on the NCI funding for cancer training webpage! A wizard that will help find relevant cancer training funding opportunities based on your career stage.
Check it out and tell your colleagues!
|
|
|
Apply for Extension to NIH Early-Stage Investigator Status
 Are you an NIH Early-Stage Investigator? Has your research been negatively impacted by COVID-19 or other life events? If so, you may be eligible for an extension to your NIH ESI status. Find out how to access the link for requesting an ESI extension.
If you have experienced a lapse in your research or research training or experienced periods of less than full-time effort, you are encouraged to apply for an extension to your ESI status. NIH considers ESI extension requests for COVID-19, medical concerns, disability, family care responsibilities, extended periods of clinical training, natural disasters, and active-duty military service. Extensions are determined on a case-by-case basis at the sole discretion of the NIH. Read here for instructions on how to complete and submit the NIH ESI extension request form. |
|
|
NIH Family Friendly Policies for Extramural Researchers and Trainees
 Family Friendly Policies are integral not only to ensuring we maintain a strong scientific workforce, but also a more diverse one. NIH supports various programs and policies fostering a balanced work and family life from funding available for childcare costs to extensions of ESI status. Learn more about these Family Friendly Initiatives at the NIH All About Grants podcast on NIH Family Friendly Policies. |
|
|
The Population Science Department uses the collective expertise of epidemiologists, biostatisticians, and behavioral scientists to better understand the behavioral, social, environmental, and biologic factors that affect cancer prevention, risk, survivorship, and survival. This research aims to refine personalized risk prediction and targeted intervention strategies, inform public health and clinical decision making for cancer prevention and survivorship, and reduce disparities among medically vulnerable populations. Most of the work within Population Science uses the CancerPrevention Studies (CPS), a series of large- scale prospective cohort studies built and maintained by the American Cancer Society since the 1950’s. The CPS cohorts include extensive survey-based data, other data sources such asaccelerometry, blood, stool, saliva, and tumor tissue. We are particularly interested in, but not limited to, scientists with expertise in the following areas:
- Sleep science
- Cancer Health Disparities
- Breast, endometrial, and ovarian cancer
- Gastrointestinal cancers (e.g. pancreas, colon)
- Molecular epidemiology
- Nutrition, diet patterns, or novel diet assessment
- Cancer survivorship including biologic aging
The scientists hired for these positions will initiate and direct research projects in collaboration with other intramural research scientists and the extramural scientific community that result in published peer- reviewed original research. The scientists will also serve as public spokespeople for Population Science by communicating results of their research to stakeholders-including American Cancer Society staff and volunteers, the scientific community, mainstream media, policy, and the public at large. These full-time positions offer a unique opportunity to contribute to work that has international impact.
Successful candidates should have a sustained focus on cancer epidemiology, will be expected to establish an innovative, independent research portfolio that aligns with the Society’s mission and Population Science researchpriorities, and will contribute to the scientific leadership of the CPS cohorts. Applicants must have a doctoral degree and post-doctoral training in epidemiology, behavioral science, public health, statistics/bioinformatics or a related field,as well as a consistent track-record of publication.
The positions are available immediately, and the salary is commensurate with qualifications and experience. These positions are based at the American Cancer Society’s Research Headquarters in Atlanta, GA. If you are interested, please submit a cover letter that includes a research statement and a curriculum vitae to Dr. Alpa Patel, Senior Vice President, Population Science at alpa.patel@cancer.org.
|
|
|
Notice of Special Interest (NOSI): Administrative Supplements to Recognize Excellence in Diversity, Equity, Inclusion, and Accessibility (DEIA) Mentorship
The participating Institutes and Centers (ICs) are inviting applications to support administrative supplements to existing awards of scientists who are outstanding mentors and who have demonstrated compelling commitments and contributions to enhancing diversity, equity, inclusion, and accessibility (DEIA) in the biomedical sciences. Excellent mentorship and superior training are critical to the development of exceptional future scientists. This administrative supplement recognizes the crucial role great mentors play in the development of future leaders in the scientific research enterprise.
The supplement awards will provide up to $250,000.00 (direct costs), not to exceed the cost of the parent award, to grants supporting faculty members who have mentoring and/or mentorship as part of their existing awards and have demonstrated a commitment to outstanding mentorship and training, especially to individuals from groups identified as underrepresented in the biomedical sciences (e.g., see the Notice of NIH's of Interest in Diversity). As administrative supplements, the work proposed needs to be within the scope of the research or training that is already supported. The award must have a component related to mentoring. Examples include but are not limited to: a Research Education Program that describes mentored research experiences, a Career Development section, a Plan to Enhance Diverse Perspectives, or a discrete objective related to mentoring.
For more information, visit https://grants.nih.gov/grants/guide/notice-files/NOT-OD-22-057.html.
|
|
|
New Funding Opportunity!
We are excited to let you know that NHLBI has released two companion FOAs with the entitled of “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Clinical/Community Field Centers (UG3/UH3 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-015.html and “New Epidemiological Cohort Study among Asian Americans, Native Hawaiians, and Pacific Islanders (AsA-NHPI): Coordinating Center (U24 - Clinical Trial Not Allowed)” https://grants.nih.gov/grants/guide/rfa-files/RFA-HL-23-016.html along with the notice of availability of Frequently Asked Questions (FAQs) (https://grants.nih.gov/grants/guide/notice-files/NOT-HL-22-027.html).
|
|
Save the Date: 34th AACR-NCI-EORTC Symposium on Molecular Targets and Cancer Therapeutics
October 26-28, 2022
Barcelona, Spain
The AACR-NCI-EORTC Symposium, commonly referred to as the Triple Meeting, is the premier drug development and translational research meeting, focusing on preclinical and phase I studies, enabling and facilitating in-depth scientific discussions on the latest developments in targets and drugs.
For more details, please visit Triple Meeting 2022.
|
|
Fellowship Opportunities
(NEW) NCI Post-doctoral fellowship opportunities
Cancer Research Training Award Fellowship in Health Behaviors Research
As a member of the Health Behaviors Research Branch, the fellow will work collaboratively on various projects to address cancer-related behaviors (e.g., diet and nutrition, physical activity, sleep, alcohol, medication adherence) and associated factors (e.g., genetics, family, environment, culture, policy) to advance behavioral and social science for cancer prevention and control. The program seeks candidates with a Ph.D. or equivalent degree (or highly qualified Ph.D. candidates) with a strong interest in interdisciplinary behavioral and social science research in cancer prevention and control, particularly in behavioral interventions and clinical trials, multilevel and policy research, implementation and health sciences research, and/or cross-disciplinary areas of behavioral science. See the announcement for more details.
--
Postdoctoral Fellowship in Health Equity and Basic Behavioral and Psychological Sciences Research
The Basic Biobehavioral and Psychological Sciences Branch (BBPSB) supports research fundamental to understanding human behaviors, social context, decision-making, and clinical practices associated with cancer etiology, prevention, screening, detection, diagnosis, treatment, and survivorship. Candidates trained in health equity research with a biopsychosocial background are encouraged to apply. Competitive candidates will demonstrate knowledge or interest in using their training to cultivate a health equity and cancer-relevant basic behavioral and psychological sciences research portfolio. See the announcement for more details.
|
|
Fellowship: NCI Cancer Research Training Award
The National Cancer Institute (NCI) Cancer Research Training Award is a full-time position based in Rockville, Maryland that provides opportunities for training and professional development that supports NCI Behavioral Research Program activities and contributes to the scientific literature in tobacco control and related areas of behavioral research. Start dates are January or June 2022, depending on the applicant's graduation date. Applications will be accepted until the position is filled. Please learn more here
|
|
|
NIH Stadtman Investigators
The National Institutes of Health is pleased to announce its thirteenth annual call for NIH Stadtman Investigators. These are prestigious, tenure-track positions within the NIH Intramural Research Program (IRP). NIH fosters an inclusive environment where diverse talent is leveraged to advance health discovery. We seek a diverse cadre of creative thinkers eager to take on innovative, high-impact research.
Eligibility: Applicants must have an M.D., Ph.D., Pharm.D., Psy. D., D.D.S./D.M.D., D.V.M., D.O., R.N./Ph.D., or equivalent doctoral degree.
Application Period: August 1 through September 30 at 11:59 p.m. EDT
Want to learn more? Watch the Research Careers in the NIH Intramural Research ProgramIntroductory Video.
Please learn more here
|
|
Scientific Director, Risk Factors & Screening Research
The incumbent leads the Risk Factors & Screening Research team within the Surveillance & Health Equity Science (SHES) Department of the American Cancer Society (ACS). Provides leadership for updating and publishing the biennial Cancer Prevention & Early Detection (CPED) Facts & Figures and for timely provision of risk factors and screening data for ACS senior leadership and field staffs to guide cancer control planning and measure progress. Develops collaborative working enterprises with colleagues from the SHES, other departments in the Discovery Pillar at ACS, and the American Cancer Society Cancer Action Network (ACS CAN) to identify timely and impactful research topics in the areas of cancer screening and other preventive measures. Establishes strong research collaborations on screening with private and public health organizations and cancer research networks such as the NCI, CDC, and academia. The successful candidate is a nationally recognized expert in cancer screening research and serves as the internal society expert in this area. Acts as a spokesperson to the media when needed. Supervises and mentors 2-3 staff members in the Risk factors & Screening Research team. Also, there are opportunities to mentor interns and postdocs.
For more information, click here.
|
|
|
NIH Job Opportunities
Scientific Director
Vaccine Research Center, NIAID
(review begins: July 21)
The National Institute of Allergy and Infectious Diseases (NIAID), one of the largest Institutes of the National Institutes of Health (NIH), is seeking an exceptional and visionary leader for the position of Director of the Dale and Betty Bumpers Vaccine Research Center (VRC). NIAID supports and conducts basic, applied, and clinical research to better understand, treat, and prevent infectious, immunologic, and allergic diseases.
The VRC is goal-oriented and conducts vaccine and biomedical research that leads to fundamental advances in knowledge regarding protective medical countermeasures and field-shifting biomedical technologies. The VRC's mission is to discover and develop novel vaccines and biologics targeting infectious diseases of domestic and global public health importance. The VRC applies scientific and technological innovation to: (1) optimize design and development of vaccine and biologic test products, and to carry out pilot manufacture of clinical materials under cGMP for use in first-in-human clinical studies; (2) advance regulatory science to streamline the pathway to human clinical trials; (3) evaluate investigational vaccines and antibody-based products for immunogenicity and safety; and (4) provide scientific expertise to United States government activities supporting development of efficacious vaccine and biologic test products. Additionally, the VRC is committed to fostering collaborations with domestic and international partners in academia and industry for the development, efficacy testing, and licensure of vaccines and antibody-based products. Through a translational research infrastructure, the VRC advances scientific discovery into practical and accessible public health interventions. More information about the VRC and its scope of research activities can be found at https://www.niaid.nih.gov/sites/default/files/NIAID-VRC-Brochure.pdf(PDFFile).
Scientific Director
Division of Intramural Clinical and Biological Research, NIAAA
(review begins: July 23)
The National Institute on Alcohol Abuse and Alcoholism (NIAAA) seeks a Scientific Director with creative scientific vision, strong mentorship skills, and outstanding leadership skills to guide its intramural programs (see https://www.niaaa.nih.gov/division-intramural-clinical-and-biological-research). The Scientific Director will lead the NIAAA intramural programs in collaboration with the NIAAA Clinical Director. Currently the Scientific Director allocates an approximately $57 million annual budget, in consultation with the NIAAA Director and the NIAAA Clinical Director, to intramural NIAAA laboratories and clinical programs in the NIH Clinical Center. The successful candidate will oversee a diverse group of 245 staff and fellows in conducting research in basic, translational, and clinical science and help chart the future for a vibrant NIH scientific community. The Scientific Director is advised by the NIAAA Board of Scientific Counselors, a panel comprising prominent extramural researchers. The Scientific Director reports to and advises the NIAAA Director on relevant NIAAA policies. The Scientific Director recruits and mentors new faculty and steers a vibrant training program that includes post-doctoral, pre-doctoral and post-baccalaureate researchers. Most importantly, the Scientific Director, with the investigator community, charts the future direction of NIAAA's intramural world-class research program with the aim of fulfilling the overall mission of NIAAA "to generate and disseminate fundamental knowledge about the effects of alcohol on health and well-being, and apply that knowledge to improve diagnosis, prevention, and treatment of alcohol-related problems, including alcohol use disorder, across the lifespan."
Clinical Director
National Institute of Child Health and Human Development
(review begins: August 1)
The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), a major research component of the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS), seeks to identify an outstanding Clinical Director to plan and lead NICHD's clinical research activities. The NICHD's current research emphasis includes: basic biology of reproductive health, multiple approaches to developmental biology with concentrations in cell biology, animal models, and genetics; clinical trials in and clinical studies of developmental disorders; studies of healthy human development; developmental endocrinology; neurosciences; translational imaging; and population health research. The NICHD Clinical Director reports to the Director, NICHD, and coordinates activities with the Scientific Director, NICHD. The incumbent leads a clinical research program directed toward developing a greater understanding of the biological, medical, reproductive, and behavioral aspects of normal and atypical human development. The Clinical Director fosters and develops clinical research projects that address problems related to human health and disease, particularly involving pediatrics and women's health. The role of the Clinical Director encompasses responsibility and oversight for the delivery of quality and safe patient care in the context of NICHD's clinical research programs and services. The position offers a unique and exciting opportunity for an extremely capable individual to plan and oversee NICHD's clinical research programs. The Clinical Director guides and oversees the Institute's clinical research portfolio, clinical trials, and drug and device development efforts both internally and through research agreements with leading institutions around the country to advance clinical research. The Clinical Director evaluates research efforts and establishes program priorities, allocates resources, directs the training of pre-doctoral and post-doctoral fellows, collaborates with other NIH programs, and advises the NICHD Director and senior staff on clinical research programs and on areas of scientific interest to the Institute. The incumbent plays a key role in creating and maintaining a nurturing clinical research environment that encourages creativity, collaboration among scientists from different disciplines, effective training of post-doctoral fellows and trainees, and efficient utilization of resources. The Office of the Clinical Director has a staff of 38 professional and support employees, and a current annual budget in excess of $5.7 million. The Clinical Director manages some 65 active clinical protocols, through 26 NICHD Principal Investigators and 66 Associate Investigators. Opportunities exist to work with other Institutes and Centers in NIH to advance the science of NICHD, to build collaborations with outside academic partners for research and training purposes, and to partner with industry through technology transfer or cooperative research and development agreements. The Clinical Director is expected to lead his/her own high-quality research program. Resources commensurate with the vision of the proposed program will be provided. Information on the NICHD may be found at https://www.nichd.nih.gov.
Also see:
Research Careers in the NIH Intramural Research Program
https://www.youtube.com/watch?v=UmIKgNaUmtc
The NIH Intramural Research Program
http://irp.nih.gov/
http://irp.nih.gov/careers/tenured-and-tenure-track-scientific-careers
Link to Fellowships and Positions of Interest to fellows (including Staff Scientist Positions)
https://www.training.nih.gov/
https://www.training.nih.gov/career_services/jobs
Link to NIH Jobs
https://hr.nih.gov/jobs/
New video on tips for applying through USAJobs:
https://www.youtube.com/channel/UCAGtfAdoxif6an9xM6YUIAQ
Also see FDA Jobs at:
https://www.fda.gov/AboutFDA/WorkingatFDA/default.htm
|
|
|
Follow us on Facebook and Twitter or click to visit our GMaP R1S website.
|
|
|
|
|
We want to encourage all of our GMaP R1S members to share your research with us via the gmap email address: gmapregion1s@gmail.com, for dissemination throughout our network, so members across the region have the ability to access your recent work.
|
|
|
|
|
|
